AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.84
-0.42 (-6.64%)
At close: Sep 17, 2025, 4:00 PM EDT
6.11
+0.28 (4.71%)
After-hours: Sep 17, 2025, 7:13 PM EDT
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $177.93 million as of September 17, 2025. Its market cap has decreased by -27.49% in one year.
Market Cap
177.93M
Enterprise Value
206.83M
1-Year Change
-27.49%
Ranking
Category
Stock Price
$5.84
Market Cap Chart
Since March 29, 2012, AVITA Medical's market cap has increased from $59.55M to $177.93M, an increase of 198.81%. That is a compound annual growth rate of 8.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 177.93M | -47.39% |
| Dec 31, 2024 | 338.19M | -4.00% |
| Dec 29, 2023 | 352.28M | 111.74% |
| Dec 30, 2022 | 166.38M | -44.28% |
| Dec 31, 2021 | 298.61M | -25.68% |
| Dec 31, 2020 | 401.79M | -58.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |